Modern Healthcare - - NEWS MAKERS -

Fo­cal Ther­a­peu­tics, a Por­tola Val­ley, Calif.-based med­i­cal de­vice com­pany, named Steve Gex CEO, ef­fec­tive April 28.

Gex, 59, joins Fo­cal af­ter hav­ing served as CEO of sev­eral start-up com­pa­nies, in­clud­ing Biop­sys Med­i­cal and BioLu­cent. Biop­sys Med­i­cal made a breast cancer

biopsy de­vice be­fore be­ing sold to John­son & John­son. Ho­logic ac­quired BioLu­cent, which made a cush­ion to min­i­mize pain dur­ing mam­mog­ra­phy.

Fo­cal Ther­a­peu­tics de­vel­ops and man­u­fac­tures the BioZorb sur­gi­cal marker, a de­vice that pro­vides ra­dio­graphic mark­ing of soft-tis­sue sites. Ge­orge Her­mann, pres­i­dent of Fo­cal Ther­a­peu­tics, and Dr. Gail Le­bovic, the com­pany’s

chief med­i­cal of­fi­cer, have pre­vi­ously worked with Gex to build sev­eral com­pa­nies.


Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.